"69097-561-03" National Drug Code (NDC)

Lopinavir And Ritonavir 60 TABLET in 1 BOTTLE (69097-561-03)
(Cipla USA Inc.)

NDC Code69097-561-03
Package Description60 TABLET in 1 BOTTLE (69097-561-03)
Product NDC69097-561
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameLopinavir And Ritonavir
Non-Proprietary NameLopinavir And Ritonavir
Dosage FormTABLET
UsageORAL
Start Marketing Date20200626
Marketing Category NameANDA
Application NumberANDA090371
ManufacturerCipla USA Inc.
Substance NameLOPINAVIR; RITONAVIR
Strength100; 25
Strength Unitmg/1; mg/1
Pharmacy ClassesHIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/69097-561-03